All posts by: Michael Zand

About Michael Zand

Common Serious Side-Effect Of CAR T-Cell Therapy May Be Preventable – Forbes

Continue reading

2018-05-28 NEWS

Forbes

Common Serious Side-Effect Of CAR T-Cell Therapy May Be Preventable
Forbes
It has been a good month for CAR T-Cell therapies. On May 1st, the FDA handed out an approval to Novartis’s controversially-priced Kymriah for treating adults with certain types of non-Hodgkin lymphoma. Today, simultaneous discoveries from scientists

Continue reading

2018-05-28 NEWS

Herald Sun

Cancer-killing CAR T-cell immunotherapy to become more accessible to patients
Herald Sun
CAR T-cell therapy involves removing a patient’s immune cells, re-engineering them and infusing them back to create a “designer” immune system, usually as a last-ditch attempt to save their life. While still experimental, it has been able to “melt

Continue reading

2018-05-28 NEWS

India Times

New Rice Variety Created By CRISPR Gene-Edit Technology Can Yield Up To 31% More Grain Per Crop
India Times
According to an Engadget report, through the use of CRISPR/Cas9 gene editing scientists have created a rice plant variety that produces 25 to 31 percent more grain per plant in real world tests — obviously, a lot more than what you’d otherwise get
Gene-edited rice plants could boost the world’s food supplyEngadget
Can We Boost the World’s Food Supply with Gene-Edited Rice?Great Lakes Ledger

all 3 news articles »